← Open Payments lookup

ROSE CLIFFORD: Open Payments

NPI 1730285602 · GAUTIER, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,031 in 45 payments from 10 companies in 2025. Trend: 2023 $6,707 · 2024 $1,280 · 2025 $1,031

Food & beverage: $1,031
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$288
Axsome Therapeutics, Inc.8$210
ABBVIE INC.10$172
Lundbeck LLC4$93
Janssen Pharmaceuticals, Inc5$88
Otsuka America Pharmaceutical, Inc.4$78
Vanda Pharmaceuticals Inc.2$43
E.R. Squibb & Sons, L.L.C.1$24
Alkermes, Inc.1$18
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: CAPLYTA, Auvelity, VRAYLAR, REXULTI, SPRAVATO, FANAPT, COBENFY, ARISTADA.

Industry payments across MS — which companies pay providers there.